Article

Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease

2021-11-09

Abstract excerpt

<h4>ABSTRACT</h4> The response by vaccine developers to the COVID-19 pandemic has been extraordinary with effective vaccines authorized for emergency use in the U.S. within one year of the appearance of the first COVID-19 cases. However, the emergence of SARS-CoV-2 variants and obstacles with the global rollout of new vaccines highlight the need for platforms that are amenable to rapid tuning and stable formulati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 43a5b565-e91e-5e25-8ecb-5903a8dd3012
DOI: 10.1101/2021.11.08.467648

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and diseaseDOI 10.1101/2021.11.08.467648Read

Design and proof-of-concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chainSemantic proximity Read

Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriersSemantic proximity Read

Nanoparticle-Conjugated TLR9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 VaccinesSemantic proximity Read

Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2Semantic proximity Read

Viral nanoparticles and virus‐like particles: platforms for contemporary vaccine designSemantic proximity Read

Bacteriophage T4 as a Protein-Based, Adjuvant- and Needle-Free, Mucosal Pandemic Vaccine Design PlatformSemantic proximity Read

A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineeringSemantic proximity Read

Tailored Viral-Like Particles as Drivers of Medical BreakthroughsSemantic proximity Read

Inhalable SARS-CoV-2 vaccine for single-dose dry powder aerosol immunizationSemantic proximity Read

A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primatesSemantic proximity Read

Inducing Long Lasting B Cell and T Cell Immunity Against Multiple Variants of SARS-CoV-2 Through Mutant Bacteriophage Qβ-Receptor Binding Domain Conjugate.Semantic proximity Read

Elicitation of potent SARS-CoV-2 neutralizing antibody responses through immunization with a versatile adenovirus-inspired multimerization platformSemantic proximity Read